Secondary pseudomonas infection of fungal keratitis following use of contaminated natamycin eye drops: A case series

Eye

Volumn 23, Issue 2, 2009, Pages 477-479

  Krishnan, T ^a   Sengupta, S ^a   Reddy, P R ^a   Ravindran, R D ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

Fungal keratitis; Natamycin; Pseudomonas

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; EYE DROPS; GATIFLOXACIN; GENTAMICIN; IMIPENEM; ITRACONAZOLE; MEROPENEM; NATAMYCIN; NETILMICIN; OFLOXACIN; TOBRAMYCIN; ANTIFUNGAL AGENT;

ARTICLE; ASPERGILLUS; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG CONTAMINATION; DRUG SUBSTITUTION; EVISCERATION; FEMALE; FUSARIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; KERATITIS; KERATOMYCOSIS; KERATOPLASTY; MALE; NONHUMAN; PANOPHTHALMITIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; VISION; ADULT; CASE REPORT; COMPLICATION; EYE INFECTIONS, FUNGAL; PSEUDOMONAS INFECTIONS;

ADULT; ANTIFUNGAL AGENTS; DRUG CONTAMINATION; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; MALE; NATAMYCIN; OPHTHALMIC SOLUTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 60149093366     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.290     Document Type: Article

References (18)

1. Rosa RH, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994; 101(6): 1005-1013.
2. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 15(4): 321-327.
3. Thomas PA. Fungal infections of the cornea. Eye 2003; 17(8): 852-862.
4. Kanal B, Deb M, Panda A, Sethi HS. Laboratory diagnosis in ulcerative keratitis. Opthalmic Res 2005; 37(3): 123-127.
5. Leck AK, Thomas PA, Hagan M, Kaliamurthy J, Ackuaku E, John M et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002; 86: 1211-1215.
6. Jayahar MB, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Ind J Ophthalmol 2003; 51(4): 315-321.
7. Jayahar MB, Ramakrishnan R, Meenakshi R, Padmavathy S. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 2007; 14(2): 61-69.
8. Zhou Q, Takenaka S, Murakami S, Seesuriyachan P, Kuntiya A, Aoki K. Screening and characterization of bacteria that can utilize ammonium and nitrate ions simultaneously under controlled cultural conditions. J Biosci Bioeng 2007; 103(2): 185-191.
9. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008; 27(1): 22-27.
10. Pate JC, Jones DB, Wilhelmus KR. Prevalence and spectrum of bacterial co-infection during fungal keratitis. Br J Ophthalmol 2006; 90: 289-292.
11. Rahman MQ, Tejwani D, Wilson JA, Butcher I, Ramaesh K. Microbial contamination of preservative free eye drops in multiple application containers. Br J Ophthalmol 2006; 90: 139-141.
12. Konemann EW, Allan SD, Janda WM, Schreckenberger PC, Winn Jr WC et al. Color Atlas and Textbook of Diagnostic Microbiology, 5th edn Lippincott Raven Publishers, 1997, pp 120-133.
13. Arora DR. Quality assurance in microbiology. Indian J Med Microbiol 2004; 22(2): 81-86.
14. Fong CF, Hu FR, Tseng CH, Wang IJ, Chen WL, Hou YC. Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan. Am J Ophthalmol 2007; 144(5): 682-689.
15. Hu FR, Luh KT. Pseudomonas aeruginosa isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination. J Formos Med Assoc 1992; 91(2): 190-194.
16. Ivanov DV, Krapivina IV. Etiology of nosocomial surgical infections caused by gram-negative bacteria, and profile of their antibiotic resistance. Zh Mikrobiol Epidemiol Immunobiol 2007; (5): 90-93.
17. Sánchez-Romero I, Cercenado E, Cuevas O, García-Escribano N, García-Martínez J, Bouza E, Spanish Group for Study of Pseudomonas aeruginosa. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003). Rev Esp Quimioter 2007; 20(2): 222-229.
18. Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect 2007; 40(1): 45-49.